CCI clears merger of nine pharma entities with Sequent Scientific
Sequent Scientific Ltd (SSL). «The proposed combination involves a series of inter-connected steps carried out for the amalgamation of SRL, Viyash, Symed, Appcure, Vindhya Pharma, Vandana, Vindhya Organics, Geninn and SV Labs with SSL as the ultimate surviving entity,» CCI (Competition Commission of India) said in a release.
Budget with ET
Sitharaman has one job to do and it’s the most crucial one yet
Will Modi govt have something special for Nitish Kumar’s Bihar?
Budget should help in safeguarding India’s trade interests as Trump returns
SSL offers active pharmaceutical ingredients (APIs), finished dosage formulations, and analytical services for the animal health sector.
Sequent Research Ltd (SRL), a wholly-owned subsidiary of SSL, is a contract research organisation.
Viyash is a pharmaceutical company and through its subsidiaries is primarily engaged in the development, manufacture and sale of APIs and intermediates for human healthcare in India.
Symed Labs, Appcure Labs, Vindhya Pharma (India) and Vandana Life Sciences are wholly-owned subsidiaries of Viyash while S V Labs is a wholly owned step-down subsidiary of Viyash.
Artificial Intelligence(AI)
Java Programming with ChatGPT: Learn using Generative AI
By — Metla Sudha Sekhar, IT Specialist and Developer
Artificial Intelligence(AI)
Basics of Generative AI: Unveiling Tomorrows Innovations
By — Metla Sudha Sekhar, IT Specialist and Developer
Artificial Intelligence(AI)
Generative AI for Dynamic Java Web Applications with ChatGPT
By — Metla Sudha Sekhar, IT
